Related Experiment Video
Updated: Jan 15, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Pre-packaged food targeted to gastrointestinal pathologies: are they low in FODMAP?
Sara Barreirinhas1,2, Carla Almeida1,3,4, Susana Casal5
1Faculdade de Ciências da Nutrição e Alimentação da Universidade do Portohttps://ror.org/043pwc612, Porto, Portugal.
Abstract:
A diet low in fermentable carbohydrates, oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) has been described as an effective nutritional approach in irritable bowel syndrome. There has been an increased demand for gluten- and lactose-free foodstuffs in the last few years, which are associated with gastrointestinal symptoms and are consumed by patients with gastrointestinal disease. This study aims to estimate the FODMAP content of industrial pre-packaged food products containing the ‘gluten-free’ and ‘lactose-free’ claims. The ingredient lists of the foodstuffs from a Portuguese food retail chain were verified and classified according to their estimated FODMAP content as ‘low’ and ‘high’, using as a reference the FODMAP cutoff values and the serving sizes established by the Monash University App. Descriptive statistics and the Pearson χ2 test were applied. From the 436 eligible products identified, most were classified as ‘low’ (53·0 %, n 231), 24·3 % (n 106) were classified as ‘high’ and 22·7 % (n 99) were classified as having ‘unknown’ FODMAP content. ‘High FODMAP’ products accounted for 12·2 % of those with ‘lactose-free’ claims and 31·6 % of those with ‘gluten-free’ claims. The ‘ready meals’ and ‘sauces, dressings, creams and soups’ were the food categories with the highest proportion of products with high FODMAP sources. This study showed that approximately a quarter of pre-packaged industrial foods targeted to gastrointestinal pathologies are high in FODMAP. The nutritional information on the label should be more specific, enabling more accurate dosing of FODMAP contents in foodstuffs and the establishment of the recommended serving sizes.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Gastrointestinal Motility Disorders
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Constipation-Predominant IBS

